← Back to headlines
Analysis on Bristol Myers Squibb Stock and Dividend Yield
An analysis explores whether investors should consider buying Bristol Myers Squibb stock, focusing on its 4.4%-yielding dividend.
23 Mar, 20:50 — 23 Mar, 20:50
Sources
Showing 1 of 1 sources
